Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

NCT04136002 is registered in ClinicalTrials.gov with Guardant Health, Inc. as lead sponsor.

NCT NCT04136002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04136002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Lead sponsor
Guardant Health, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
October 8, 2019
Completion date
August 5, 2027
Enrollment
44,467 (actual)
Sites
271

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer